Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Breyanzi
Manufacturing
BMS calls it quits on vector production at former Novartis plant
Two years after securing a former Novartis gene therapy facility in Illinois, Bristol Myers Squibb is rethinking its operations at the site.
Fraiser Kansteiner
May 2, 2025 11:20am
BMS angles Breyanzi for another blood cancer
Feb 10, 2025 9:50am
Pfizer, BMS and more start 2025 with drug price hikes: report
Jan 2, 2025 10:42am
FDA revisits CAR-T boxed warning on secondary cancers: Marks
Nov 1, 2024 10:30am
BMS skates again on $6.4B Celgene shareholder lawsuit
Oct 1, 2024 10:45am
Bristol Myers secures another FDA go-ahead for Breyanzi
May 30, 2024 1:32pm
